sexta-feira, 13 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 5, 2026

Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy?

View original at finance.yahoo.com
Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy? Shares of Wells Fargo & Company WFC have gained 18.6% in the past three months compared with the industry’s rise of 9.1%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Wells Fargo carries Zacks Rank #2 (Buy)

    80% confidence
  • Wells Fargo stock worth investing in now for solid long-term returns

    80% confidence
  • Wells Fargo expects to achieve $15 billion in gross expense savings by end of 2025

    80% confidence
  • Management characterized AI transition as a 'positive reality' suggesting AI-enabled efficiencies will support long-term operational improvements

    80% confidence
  • Zacks Consensus Estimate for WFC 2025 earnings indicates 16.9% rally

    80% confidence
  • Zacks Consensus Estimate for WFC 2025 sales suggests 2.1% growth

    80% confidence
  • Wells Fargo plans to introduce AI gradually over next year and continue expanding use beyond 2026

    80% confidence
  • Wells Fargo expects 2025 NII to be in line with 2024 NII of $47.7 billion

    80% confidence
  • By end of 2025, slightly more than half of branch network expected to be refreshed

    80% confidence
  • Wells Fargo targets up to $10 billion in annual cost cuts

    80% confidence
  • Wells Fargo signaled workforce could shrink in 2026 as part of push to improve efficiency and incorporate AI

    80% confidence
  • Zacks Consensus Estimate for WFC 2026 sales suggests 5.4% growth

    80% confidence
  • Zacks Consensus Estimate for WFC 2026 earnings indicates 11.7% rally

    80% confidence
  • Wells Fargo raised medium-term ROTCE target to 17-18% from earlier 15%

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy? — Source | Via News | pt.VIA.NEWS